Search

Displaying all 5 results
DrugBest match

Fitusiran

go.drugbank.com/drugs/DB15002
ApprovedInvestigational

Fitusiran is an antithrombin-directed double-stranded small interfering ribonucleic acid (siRNA) that is covalently linked to a ligand containing a triantennary N-acetylgalactosamine (GalNAc) moiety. Fitusiran was first approved by the FDA on March 28, 2025, as routine prophylaxis therapy to prevent or reduce the fr...

  1. Indication

    Bleeding caused by Hemophilia B Without Inhibitor

    go.drugbank.com/conditions/DBCOND0170628
    Drugs: Fitusiran · Marstacimab
  2. Indication

    Bleeding caused by Hemophilia A Without Inhibitor

    go.drugbank.com/conditions/DBCOND0170627
    Drugs: Fitusiran · Marstacimab
  3. Indication

    Bleeding caused by Hemophilia B

    go.drugbank.com/conditions/DBCOND0089514
    Drugs: Anti-inhibitor coagulant complex · Coagulation Factor IX Human · Coagulation factor VIIa Recombinant Human · Eftrenonacog alfa · Fitusiran · Nonacog beta pegol
  4. Indication

    Bleeding caused by Hemophilia A

    go.drugbank.com/conditions/DBCOND0089512
    Drugs: Anti-inhibitor coagulant complex · Coagulation factor VIIa Recombinant Human · Emicizumab · Fitusiran · Moroctocog alfa · Rurioctocog alfa pegol +2 more